2.3 Million New Female Breast Cancer Cases Seen Globally in 2022

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Feb. 24, 2025 -- In 2022, there were 2.3 million new breast cancer cases and 670,000 deaths from female breast cancer globally, according to a study published online Feb. 24 in Nature Medicine.

Joanne Kim, Ph.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues examined the current (2022) and future (2050) global burden of female breast cancer overall and by age group in 185 countries and assessed 10-year trends in incidence and mortality rates in 50 and 46 countries, respectively.

The researchers found that in 2022, there were 2.3 million new breast cancer cases and 670,000 deaths from female breast cancer worldwide. In half of examined countries, annual rates increased by 1 to 5 percent. In 29 countries with a very high Human Development Index (HDI), mortality rates decreased, and seven countries are currently meeting the Global Breast Cancer Initiative goal of ≥2.5 percent decrease each year. New cases and deaths are projected to increase by 38 and 68 percent, respectively, by 2050, disproportionately impacting low-HDI countries.

"Sustained investment and improvement in early diagnosis and treatment are also urgently needed, particularly in low- and medium-HDI countries, to reduce growing inequities in breast cancer survival and mitigate poor outcomes for the millions of additional women who will receive a diagnosis of breast cancer in the coming years," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-25 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords